1. Home
  2. FATE vs BTM Comparison

FATE vs BTM Comparison

Compare FATE & BTM Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • FATE
  • BTM
  • Stock Information
  • Founded
  • FATE 2007
  • BTM 2016
  • Country
  • FATE United States
  • BTM United States
  • Employees
  • FATE N/A
  • BTM N/A
  • Industry
  • FATE Biotechnology: Biological Products (No Diagnostic Substances)
  • BTM Finance: Consumer Services
  • Sector
  • FATE Health Care
  • BTM Finance
  • Exchange
  • FATE Nasdaq
  • BTM Nasdaq
  • Market Cap
  • FATE 177.7M
  • BTM 144.5M
  • IPO Year
  • FATE 2013
  • BTM N/A
  • Fundamental
  • Price
  • FATE $1.14
  • BTM $5.42
  • Analyst Decision
  • FATE Hold
  • BTM Strong Buy
  • Analyst Count
  • FATE 7
  • BTM 2
  • Target Price
  • FATE $3.83
  • BTM $4.75
  • AVG Volume (30 Days)
  • FATE 1.9M
  • BTM 1.9M
  • Earning Date
  • FATE 08-12-2025
  • BTM 08-12-2025
  • Dividend Yield
  • FATE N/A
  • BTM N/A
  • EPS Growth
  • FATE N/A
  • BTM N/A
  • EPS
  • FATE N/A
  • BTM N/A
  • Revenue
  • FATE $13,335,000.00
  • BTM $599,390,000.00
  • Revenue This Year
  • FATE N/A
  • BTM $10.59
  • Revenue Next Year
  • FATE N/A
  • BTM $4.27
  • P/E Ratio
  • FATE N/A
  • BTM N/A
  • Revenue Growth
  • FATE 105.85
  • BTM N/A
  • 52 Week Low
  • FATE $0.66
  • BTM $0.93
  • 52 Week High
  • FATE $5.92
  • BTM $6.88
  • Technical
  • Relative Strength Index (RSI)
  • FATE 46.69
  • BTM 56.75
  • Support Level
  • FATE $1.05
  • BTM $4.70
  • Resistance Level
  • FATE $1.18
  • BTM $6.21
  • Average True Range (ATR)
  • FATE 0.08
  • BTM 0.48
  • MACD
  • FATE -0.00
  • BTM -0.09
  • Stochastic Oscillator
  • FATE 54.76
  • BTM 58.39

About FATE Fate Therapeutics Inc.

Fate Therapeutics Inc is a clinical-stage biopharmaceutical company based in the United States. It is engaged in the development of programmed cellular immunotherapies for cancer and autoimmune disorders. The company's cell therapy pipeline is comprised of NK- and T-cell immuno-oncology programs, including off-the-shelf engineered product candidates derived from clonal master iPSC lines, and immuno-regulatory programs, including product candidates to prevent life-threatening complications in patients.

About BTM Bitcoin Depot Inc.

Bitcoin Depot Inc owns and operates the widest network of BTMs across North America where customers can buy and sell Bitcoin. Bitcoin Depot helps power the digital economy for users of cash. It has locations across the U.S. and Canada at, among others, the following types of retailers: Convenience Stores and Gas Station Chains, Pharmacies and Grocers and Mall Operators.

Share on Social Networks: